Literature DB >> 3015639

Morphine-induced opioid receptor down-regulation detected in intact adult rat brain cells.

N F Rogers, E el-Fakahany.   

Abstract

Intact brain cells dissociated from the brains of adult rats were used to study the regulation of opioid receptors by in vivo chronic morphine treatment. When the specific binding of [3H]naloxone in a physiological iso-osmotic buffer was compared in cells obtained from sham-operated rats and in those treated for 6 days with four (2 X 2) 75 mg morphine pellets, it was found that morphine treatment resulted in a significant reduction in the density of [3H]naloxone binding sites. This receptor down-regulation was not accompanied by a change in the receptor affinity for the ligand. This effect of morphine was reversed upon the removal of morphine pellets for 18 h after tolerance induction. When similar experiments were performed using brain homogenates prepared and assayed in the same physiological buffer, there was an increase in the number of [3H]naloxone binding sites in morphine-treated animals compared to controls. On the other hand, when the binding experiments were conducted in 50 mM Tris-HCl buffer, no difference in ligand binding was apparent between control and morphine-treated groups. The present results demonstrate opioid receptor down-regulation by chronic morphine treatment measured in intact brain cells, and suggest that different conclusions may be reached when other tissue preparations are used to assess the receptor density.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3015639     DOI: 10.1016/0014-2999(86)90223-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

Review 1.  Pathophysiology of opioid tolerance and clinical approach to the opioid-tolerant patient.

Authors:  O de Leon-Casasola; A Yarussi
Journal:  Curr Rev Pain       Date:  2000

2.  Evidence for crosstolerance to the analgesic effects between morphine and selective alpha 2-adrenoceptor agonists.

Authors:  C Post; T Archer; B G Minor
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

3.  Down-regulation of 3H-lofentanil binding to opiate receptors in different cultured neuronal cells.

Authors:  J M Maloteaux; J N Octave; E C Laterre; P M Laduron
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989 Jan-Feb       Impact factor: 3.000

4.  Selective changes in mu opioid receptor properties induced by chronic morphine exposure.

Authors:  L L Werling; P N McMahon; B M Cox
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

5.  Production of antinociception by peripheral administration of [Lys7]dermorphin, a naturally occurring peptide with high affinity for mu-opioid receptors.

Authors:  L Negri; R Lattanzi; P Melchiorri
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

6.  Modulation of brain alpha 2-adrenoceptor and mu-opioid receptor densities during morphine dependence and spontaneous withdrawal in rats.

Authors:  I Ulibarri; J A García-Sevilla; L Ugedo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-11       Impact factor: 3.000

7.  The interaction of the mu-opioid receptor and G protein is altered after chronic morphine treatment in rats.

Authors:  P L Tao; C R Lee; P Y Law; H H Loh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-11       Impact factor: 3.000

8.  mu-Opioid receptor and alpha 2-adrenoceptor agonist binding sites in the postmortem brain of heroin addicts.

Authors:  A M Gabilondo; J J Meana; F Barturen; M Sastre; J A García-Sevilla
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

9.  The Effect of Adding Sufentanil to 0.5% Hyperbaric Bupivacaine on Duration of Brachial Plexus Blockade in Chronic Opium Abusers: a Randomized Clinical Trial.

Authors:  Omid Azimaraghi; Seyed Mojtaba Marashi; Noushin Khazaei; Sarah Pourhassan; Ali Movafegh
Journal:  Anesth Pain Med       Date:  2015-06-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.